Redesign Health
also invests · investor profileUnicorn · $1.7BFounded 2018 · 256 employees on LinkedIn · 9 known investors
Redesign Health is a venture capital and applied technology platform that builds and invests in next-generation healthcare companies using AI-native strategies. The firm partners with founders and existing businesses to develop solutions addressing healthcare system inefficiencies across prediction, personalization, and care delivery.
Also known as Redesign
Investors · 9
Also in the syndicate · 2
Valuation · disclosed
Disclosed eventsSource: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Company profile
researched Aug 2026Redesign Health is a healthcare venture builder and investment platform founded in 2018 and headquartered in New York. It describes itself as a global venture and applied technology platform focused on building next-generation healthcare companies, partnering with founders as well as existing businesses through venture capital and buyout strategies. The firm engages founders at the earliest stage — before a company is started — supplying research, ideation and diligence support, commercial relationships with payers and providers, codified operating playbooks, talent pipelines and capital.
The firm's investment work is organized around eight thematic areas: addressing the healthcare labor shortage, accelerating value-based and longitudinal care, liberating data/interoperability, preparing for an aging population, eliminating barriers to health equity, expanding sites of care, growing the insured population, and personalization and consumerization of healthcare. Within these themes it defines narrower "Opportunity Zones" such as workforce management, chat-based care combining human experts and large language models, and comprehensive preventive care. Portfolio and incubated companies cited across sources include Scriptology, UpLift, Vivid Health, Baton, Calibrate, Motto, Proper, DUOS, Corvus, Translucent, Lively, Vault Health, Linea, Cascala Health and Nuxera AI.
Redesign Health positions itself as operating like the AI-native companies it backs, centering an internal AI knowledge graph built from expert research and relationships with healthcare institutions and decision makers, used to match founders with institutions, capital with opportunities and technology with problems.
Founding story
Redesign Health was founded in 2018 by Brett Shaheen with Laura Bagnoli, Leann Arkema and Susan Leonelli. Shaheen, who previously worked at Goldman Sachs, The Carlyle Group and Lone Pine Capital, became interested in healthcare venture funding after helping start the dental company Candid in 2017. Declaration Partners is described as a founding investor.
Business model
Redesign Health researches healthcare pain points, then builds, brands, launches and funds new healthcare companies, recruiting outside founders to lead them; it also invests in and pursues buyouts of existing businesses. It supplies portfolio companies with research, institutional relationships, operating playbooks, talent and commercial and technical support from investment through exit.
Capital is deployed from funds raised from institutional investors; the firm holds equity in the companies it creates and backs, with value realized through exits such as the acquisition of portfolio company Lively by GN Hearing.
Traction
Since 2018 the firm and its portfolio companies have touched more than 15 million patients and raised over $1.5 billion, per the company's site. Third-party sources report more than 60 companies launched (with one 2025 account citing more than 70) and over $1 billion in cumulative portfolio revenue. Portfolio outcomes include GN Hearing's acquisition of Lively and follow-on raises at DUOS ($130M), Vault Health ($30M) and Translucent ($27M Series A).
Latest developments
The December 2024 fund is earmarked for roughly 20 new companies in areas including healthy aging, expanding sites of service and interoperability. The firm has announced a digital health venture platform with Cedars-Sinai, a partnership with Sanabil Investments in Saudi Arabia including a Sanabil Venture Studio that funded Nuxera AI with $2.5 million, and recent portfolio activity including Corvus (backed with Mayo Clinic), Linea's heart failure platform with DaVita backing and Cascala Health's $8.6 million raise. Its current positioning emphasizes AI-native venture capital and buyout strategies.
▸Full profile — market position, technology, go-to-market, geography, history, risks & controversies
Market position
Positioned between an incubator and a venture capital firm, focused exclusively on healthcare and, per its own description, on AI-native healthcare company creation; it makes the key decisions for the ventures that spin out of it. Its December 2024 fund was its largest to date at $175 million.
Unlike a conventional venture fund, Redesign Health originates company ideas internally from proprietary research and then recruits founders, retaining decision rights over spin-outs. It cites an AI knowledge graph of expert research and institutional relationships, codified playbooks, and established payer and provider networks as the infrastructure founders plug into.
Technology
The firm maintains an AI knowledge graph built on internal expert research and hundreds of thousands of institutional and decision-maker relationships, traversed jointly by staff and software agents. Its investment framework emphasizes enabling AI technologies including agentic methods, generative models, voice and conversational interfaces, multimodal AI and predictive AI, alongside explainability and licensed human-in-the-loop oversight.
Go-to-market
Redesign Health sources founders directly through open outreach on its site and careers channels, and builds companies in partnership with healthcare institutions; it has formed venture platform partnerships such as those with Cedars-Sinai and Sanabil Investments in Saudi Arabia.
Healthcare founders and would-be founders, existing healthcare businesses, and institutional partners including health systems, payers and technology companies.
Geography
Headquartered in New York with a hybrid NYC office and remote staff across the United States; the firm describes itself as a global platform and has a partnership with Sanabil Investments in Saudi Arabia.
History
Founded in 2018 in New York, the firm raised capital in March 2020 and a $65 million round led by General Catalyst in September 2022 that also included CVS Health Ventures and UPMC Enterprises. In December 2024 it closed a $175 million fund — $25 million larger than its prior 2021 fund — backed by Declaration Partners, Euclidean Capital and True North Advisors, expected to support more than 20 additional companies. Over time it has launched more than 60 companies and expanded into international partnerships and AI-focused strategies.
Risks & controversies
Commentary cited by the American Hospital Association notes limitations of the model: many early-stage companies in the space do not yet accept insurance, and patients with multiple chronic conditions may face fragmentation from managing relationships with several separate providers.
Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Founder mafia
5 people who came through Redesign Health went on to found or lead other companies.
Competitors · 2
by search overlap
Companies competing with Redesign Health for the same Google search keywords, organic and paid, via search-intersection analysis.
Timeline · 6
launches, deals, and filings$2.5M source ↗
Announced a $175 million fund, $25 million larger than its prior fund raised in 2021, expected to launch more than 20 companies across themes including healthy aging, sites of service and interoperability. Backed by Declaration Partners, Euclidean Capital and True North Advisors.
$175M source ↗
David Entwistle, President and CEO of Stanford Health Care, joined Redesign Health's board in August 2023.
Round led by General Catalyst with participation from CVS Health Ventures, UPMC Enterprises and others; brought total funding to $315 million.
$65M source ↗
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 8
primary sources listed
- Redesign Healthredesignhealth.com · web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Redesign Health do?
- Redesign Health is a New York-based healthcare venture builder and investment platform that launches and funds healthcare startups.
- Who are Redesign Health's investors?
- Redesign Health's investors include CVS Health Ventures, Declaration Partners, Forerunner Ventures, Foresite Capital, Mantis Capital, RiverPark Ventures, Samsung Next.